Shanghai Model Organisms Center, Inc. Stock

Equities

688265

CNE1000055L1

Healthcare Facilities & Services

End-of-day quote Shanghai S.E. 06:00:00 2024-07-01 pm EDT 5-day change 1st Jan Change
21.12 CNY -4.95% Intraday chart for Shanghai Model Organisms Center, Inc. +1.64% -45.07%
Sales 2022 303M 41.65M Sales 2023 367M 50.4M Capitalization 3B 412M
Net income 2022 -5M -687K Net income 2023 -20M -2.75M EV / Sales 2022 9.28 x
Net cash position 2022 1.01B 139M Net cash position 2023 930M 128M EV / Sales 2023 5.64 x
P/E ratio 2022
-700 x
P/E ratio 2023
-148 x
Employees 777
Yield 2022 *
-
Yield 2023
0.34%
Free-Float 26.5%
More Fundamentals * Assessed data
Dynamic Chart
Shanghai Model Organisms Center CFO Steps Down MT
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024. CI
Shanghai Model Organisms Center, Inc.'s Equity Buyback announced on February 24, 2024, has expired with 788,912 shares, representing 1.02% for CNY 21.45 million. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on February 24, 2024. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023. CI
Shanghai Model Organisms Center, Inc. announces an Equity Buyback for CNY 30 million worth of its shares. CI
Shanghai Model Organisms Center, Inc. authorizes a Buyback Plan. CI
Shanghai Model Organisms Center, Inc.'s Equity Buyback announced on September 28, 2023 has closed with 451,318 shares, representing 0.58% for CNY 16.48 million. CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023. CI
Certain A Shares of Shanghai Model Organisms Center, Inc. are subject to a Lock-Up Agreement Ending on 28-DEC-2023. CI
Shanghai Model Organisms Center, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Shanghai Model Organisms Center, Inc.'s Equity Buyback Plan announced on September 28, 2023. CI
Shanghai Model Organisms Center, Inc. announces an Equity Buyback for CNY 30 million worth of its shares. CI
More news
1 day-4.95%
1 week+1.64%
Current month+1.34%
1 month-17.50%
3 months-23.73%
6 months-45.00%
Current year-45.07%
More quotes
1 week
20.34
Extreme 20.34
22.29
1 month
20.20
Extreme 20.2
24.35
Current year
20.20
Extreme 20.2
38.64
1 year
20.20
Extreme 20.2
47.97
3 years
20.20
Extreme 20.2
82.00
5 years
20.20
Extreme 20.2
82.00
10 years
20.20
Extreme 20.2
82.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 12-04-30
Chairman 61 16-05-31
Chairman 59 00-09-19
Members of the board TitleAgeSince
Director/Board Member 60 20-08-24
Director/Board Member 52 18-03-31
Chairman 59 00-09-19
More insiders
Date Price Change Volume
24-07-02 21.12 -4.95% 380,749
24-07-01 22.22 +6.62% 608,411
24-06-28 20.84 -0.86% 132,263
24-06-27 21.02 -1.59% 173,425
24-06-26 21.36 +2.79% 209,623

End-of-day quote Shanghai S.E., July 01, 2024

More quotes
Shanghai Model Organisms Center Inc is a China-based company mainly engaged in gene modified animal models and related technical services. The Company's businesses include genetically modified animal model, model breeding, feeding service, efficacy evaluation and phenotypic analysis, other model biotechnology services, model purchase and sales business and other businesses. The genetically modified animal model products are divided into customized models and standardized models, mainly including genetically modified mouse models, genetically modified rat models, genetically modified nematode models and genetically modified zebrafish models. The model breeding business refers to the use of genetically modified animal models developed and produced by the issuer or existing genetically modified animal models provided by customers through natural breeding or assisted reproductive breeding.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688265 Stock